Makary walks back talk of Covid-19 vaccine risk amid internal FDA debate
Makary walks back talk of Covid-19 vaccine risk amid internal FDA debate
Makary walks back talk of Covid-19 vaccine risk amid internal FDA debate
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.